We are live on !
Find out more
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter Est. Return
+9.99%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.24B
AUM Growth
+$126M
(+6%)
Cap. Flow
-$54.1M
Cap. Flow % of AUM
Cap. Flow %
-2.42%
Top 10 Holdings %
Top 10 Hldgs %
27.48%
Holding
918
New
59
Increased
121
Reduced
345
Closed
105
Avg Time Held
2.4
years
Top 10 Avg Time Held
2.7
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Intermediate Government/Credit Bond ETF
GVI
|
+$41.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$8.37M |
| 3 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$7.5M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$7.27M |
| 5 |
Regions Financial
RF
|
+$5.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$16.9M |
| 2 |
Medtronic
MDT
|
+$14.2M |
| 3 |
Union Pacific
UNP
|
+$10.2M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$8.49M |
| 5 |
Verizon
VZ
|
+$7.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.16% |
| 2 | Technology | 15.48% |
| 3 | Healthcare | 14.71% |
| 4 | Miscellaneous | 12.93% |
| 5 | Industrials | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Nucor
NUE
$58.1B
| $171K | 0.01% |
1,296
-228
| -15% | -$31K |
2021 Q4
4 quarters
|
|
302
Pegasystems
PEGA
$5.68B
| $171K | 0.01% |
10,000
| – | – |
2017 Q1
23 quarters
|
|
303
Edwards Lifesciences
EW
$49.9B
| $170K | 0.01% |
2,273
-27
| -1% | -$2.08K |
2021 Q4
4 quarters
|
|
304
iShares Russell Mid-Cap Value ETF
IWS
$15.4B
| $169K | 0.01% |
1,607
| – | – |
2021 Q4
4 quarters
|
|
305
State Street SPDR Dow Jones REIT ETF
RWR
$1.79B
| $169K | 0.01% |
1,938
-300
| -13% | -$26.3K |
2022 Q2
2 quarters
|
|
306
Equinix
EQIX
$97.3B
| $167K | 0.01% |
255
-100
| -28% | -$61.8K |
2021 Q4
4 quarters
|
|
307
Roper Technologies
ROP
$37.9B
| $165K | 0.01% |
382
-4
| -1% | -$1.65K |
2020 Q2
10 quarters
|
|
308
Skyworks Solutions
SWKS
$18.7B
| $164K | 0.01% |
1,804
| – | – |
2021 Q4
4 quarters
|
|
309
Unum
UNM
$14.6B
| $164K | 0.01% |
4,000
-17
| -0.4% | -$712 |
2021 Q4
4 quarters
|
|
310
Worthington Enterprises
WOR
$3.16B
| $162K | 0.01% |
5,299
| – | – |
2021 Q4
4 quarters
|
|
311
Booking.com
BKNG
$123B
| $161K | 0.01% |
2,000
-13,950
| -87% | -$1.06M |
2021 Q4
4 quarters
|
|
312
Idexx Laboratories
IDXX
$44.1B
| $161K | 0.01% |
395
-37
| -9% | -$14.4K |
2020 Q2
10 quarters
|
|
313
DTE Energy
DTE
$27B
| $160K | 0.01% |
1,360
-5
| -0.4% | -$567 |
2021 Q4
4 quarters
|
|
314
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.84B
| $149K | 0.01% |
6,190
-865
| -12% | -$20.1K |
2013 Q2
38 quarters
|
|
315
McCormick & Company Non-Voting
MKC
$12.5B
| $148K | 0.01% |
1,789
-10
| -0.6% | -$806 |
2021 Q4
4 quarters
|
|
316
Boston Scientific
BSX
$64.3B
| $146K | 0.01% |
3,147
-19
| -0.6% | -$823 |
2021 Q4
4 quarters
|
|
317
XPLR Infrastructure LP
XIFR
$937M
| $146K | 0.01% |
2,080
| – | – |
2021 Q4
4 quarters
|
|
318
State Street
STT
$45.5B
| $145K | 0.01% |
1,865
-217
| -10% | -$16K |
2021 Q1
7 quarters
|
|
319
Toronto Dominion Bank
TD
$197B
| $145K | 0.01% |
2,239
-157
| -7% | -$10.1K |
2021 Q4
4 quarters
|
|
320
Ingredion
INGR
$6.18B
| $144K | 0.01% |
1,462
-38
| -3% | -$3.5K |
2021 Q4
4 quarters
|
|
321
T. Rowe Price
TROW
$21.5B
| $144K | 0.01% |
1,320
-84
| -6% | -$9.5K |
2015 Q4
28 quarters
|
|
322
iShares US Medical Devices ETF
IHI
$3.73B
| $141K | 0.01% |
2,676
| – | – |
2021 Q4
4 quarters
|
|
323
Brookfield Infrastructure Partners
BIP
$17.2B
| $139K | 0.01% |
4,499
| – | – |
2021 Q4
4 quarters
|
|
324
Enterprise Products Partners
EPD
$79.5B
| $138K | 0.01% |
5,736
-1,882
| -25% | -$46.3K |
2020 Q2
10 quarters
|
|
325
iShares ESG Aware MSCI EM ETF
ESGE
$6.48B
| $138K | 0.01% |
4,605
-3,365
| -42% | -$98.6K |
2021 Q1
7 quarters
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q4 2022 Portfolio in Review
As of Q4 2022, Cambridge Trust held 918 positions worth $2.24B, up 6% from $2.11B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Cambridge Trust's Q4 2022 filing shows 59 new, 121 increased, 345 reduced and 105 closed positions. Its largest new stake was iShares 10-20 Year Treasury Bond ETF: 21,619 shares worth $2.34M. The largest sale was iShares Core US Aggregate Bond ETF, an estimated $16.9M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Cambridge Trust's largest Q4 2022 buy was iShares 10-20 Year Treasury Bond ETF: 21,619 shares worth $2.34M.
- Cambridge Trust added most to iShares Intermediate Government/Credit Bond ETF in Q4 2022, an estimated $41.3M increase.
- Cambridge Trust's biggest Q4 2022 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $16.9M.
- Cambridge Trust fully exited Atlassian in Q4 2022, selling an estimated $589K.
- Cambridge Trust's ten largest holdings make up 27% of its $2.24B portfolio in Q4 2022.
- Cambridge Trust opened 59 new positions and closed 105 in Q4 2022.
- Cambridge Trust's portfolio value rose 6% quarter-over-quarter to $2.24B.
Based on Cambridge Trust's 13F filing for Q4 2022, filed 10 Jan 2023.